Sight Sciences, Inc.
corporate_fare Company Profile
Sight Sciences, Inc. (NASDAQ:SGHT) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 17 items for SGHT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for SGHT spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- Sight Sciences 10-Q: Q3 Revenue $24.9M, Net Loss Narrows to $6.8M, Cash $77.4M
- Sight Sciences Beats Q3, Raises FY26 Revenue Guidance to $92M-$93M
- Sight Sciences Q3 Revenue Tops Estimates at $24.9M, Gross Margin 86%
- FDA Expands TearCare Label to Improve Meibomian Gland Function, a First for Dry Eye
- Sight Sciences Q2 Revenue Beats, Raises 2026 Guidance
Financial Snapshot
Short Interest & Short Volume
4.31 days to coverFINRA reported short interest of 1,135,801 shares in SGHT as of the October 30, 2026 settlement, a 8.5% decrease from the prior period — about 4.3 days to cover at its recent average daily volume. On November 20, 2026, 24.1% of SGHT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.